J&J discontinues talc-based powder in US and Canada
21 May 2020
Johnson & Johnson (J&J) Consumer Health has discontinued talc-based Johnson’s Baby Powder in the US and Canada, but will continue selling the product in other markets around the world.
Industry News - Tag: Johnson & Johnson
You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
Sweden’s Karo gains remaining Pevaryl rights
Premium
12 May 2020
Sweden’s Karo Pharma has acquired the remaining European rights to the Pevaryl antifungal brand portfolio from Johnson & Johnson (J&J) for EUR58 million (USD63 million).
J&J steps up Tylenol production for COVID-19
Premium
16 April 2020
Johnson & Johnson’s (J&J’s) OTC sales in the US increased by more than a third in the first quarter of 2020 amid the COVID-19 pandemic. Chairman and chief executive officer Alex Gorsky said the company had increased and refocused production of Tylenol (acetaminophen).
J&J plans to streamline Consumer portfolio
Premium
23 January 2020
Johnson & Johnson (J&J) has announced plans to “rationalise” the product portfolio of its Consumer division. The news came as the division reported worldwide sales up by 2.1% on an operational basis in the fourth quarter of 2019.